American and European regulators issued safety alerts on Thursday about Multaq, a drug approved two years ago to treat abnormal heart rhythms.
The Food and Drug Administration said a study of the drug in patients with a long-term form of the disease, known as atrial fibrillation, showed twice as many deaths as those who did not take the drug.
The alerts provided the first details of a 3,000-
Technology Partners: MimirTech
Links:
[1] http://admin.indiaenvironmentportal.org.in/news/fda-issues-alerts-heart-drug-multaq
[2] http://admin.indiaenvironmentportal.org.in/category/author/duff-wilson
[3] http://admin.indiaenvironmentportal.org.in/category/newspaper/new-york-times-new-york
[4] http://admin.indiaenvironmentportal.org.in/category/thesaurus/united-states-america-us
[5] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drugs
[6] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drug-industry
[7] http://admin.indiaenvironmentportal.org.in/category/thesaurus/heart-diseases
[8] http://admin.indiaenvironmentportal.org.in/category/thesaurus/health
